INS and diabetic kidney disease: The accelerated pyruvate utilization flux after insulin administration indicates that the metabolic disturbances in the diabetic kidney during poor glycemic control are limited by substrate availability, possibly indicating a novel therapeutic target to treat diabetic nephropathy.